Dr. Jay Harrison Harvey, DO

Dr. Harvey practices at James W Aston Ambulatory Care Center in Dallas, Texas.

Dr. Harvey's NPI, 1972511517, was assigned on August 3, 2006. Dr. Harvey graduated from Texas College of Osteopathic Medicine in 1988. Dr. Harvey holds Texas license H6278.

Dr. Harvey's primary practice is James W Aston Ambulatory Care Center, at 5303 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-2300.

Dr. Harvey's primary practice is James W Aston Ambulatory Care Center in Dallas, Texas. Dr. Harvey is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Harvey to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harvey practices, 5 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Harvey's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Harvey is board certified in neurophysiology by the American Board of Clinical Neurophysiology. Dr. Harvey is licensed in Texas.

Dmand AI lists epilepsy, head injury and seizures among the conditions Dr. Harvey treats.

CMS data shows 283 Medicare services from Dr. Harvey across 8 procedure codes in 2024, for 150 Medicare patients. Medicare paid $30,530 for them.

CMS counts 150 Medicare patients who saw Dr. Harvey in 2024. The largest group is 65 to 74, with 62 patients. 73% of them have high cholesterol, and 67% have high blood pressure. 32% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harvey's median patient age at 45, with 56% women.

In 2024, Dr. Harvey wrote 1,494 Medicare Part D claims for 242 patients. 67% of them were for generic drugs. CMS names the drug for 1,309 of them, across 33 drugs with 11 or more claims each, at $1,529,748 in total drug cost. In 2023, CMS named 1,550 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Harvey for performance year 2024, reported as part of a group. Dr. Harvey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harvey as offering telehealth.

Dmand AI links 26 papers to Dr. Harvey, published from 2014 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Seizures, Electroencephalography and Epilepsy. Dr. Harvey has published most often in Annu Int Conf IEEE Eng Med Biol Soc. Dr. Harvey's most frequent co-authors are Hina N. Dave, MD, Kan Ding, MD and Ryan Scott Hays, MD.

Dmand AI links Dr. Harvey to 3 clinical trials. Conditions studied include Epilepsies, Partial, Seizures and Epilepsy.

CMS Open Payments shows 315 general payments to Dr. Harvey from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Sunovion Pharmaceuticals Inc. paid the most, $31,662. It also lists 11 research payments totaling $1,318 in 2017.

Dmand AI lists 1 award for Dr. Harvey, most recently Fellow in 2016.

Dr. Harvey graduated from Texas College of Osteopathic Medicine in 1988. Dr. Harvey is a member of AES and TMA.

Dr. Harvey is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.